ArticleThoracic cancer2023

Clinical impact of first-line PD-1 or PD-L1 inhibitors combined with chemotherapy in extensive-stage small cell lung cancer patients: A real-world multicenter propensity score-matched study.

Jingyuan Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.